1. Home
  2. SNDX vs FPF Comparison

SNDX vs FPF Comparison

Compare SNDX & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • FPF
  • Stock Information
  • Founded
  • SNDX 2005
  • FPF 2013
  • Country
  • SNDX United States
  • FPF United States
  • Employees
  • SNDX N/A
  • FPF N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • FPF Trusts Except Educational Religious and Charitable
  • Sector
  • SNDX Health Care
  • FPF Finance
  • Exchange
  • SNDX Nasdaq
  • FPF Nasdaq
  • Market Cap
  • SNDX 1.1B
  • FPF 1.1B
  • IPO Year
  • SNDX 2016
  • FPF N/A
  • Fundamental
  • Price
  • SNDX $14.41
  • FPF $18.54
  • Analyst Decision
  • SNDX Strong Buy
  • FPF
  • Analyst Count
  • SNDX 10
  • FPF 0
  • Target Price
  • SNDX $36.20
  • FPF N/A
  • AVG Volume (30 Days)
  • SNDX 2.1M
  • FPF 186.7K
  • Earning Date
  • SNDX 02-25-2025
  • FPF 01-01-0001
  • Dividend Yield
  • SNDX N/A
  • FPF 8.08%
  • EPS Growth
  • SNDX N/A
  • FPF N/A
  • EPS
  • SNDX N/A
  • FPF N/A
  • Revenue
  • SNDX $16,000,000.00
  • FPF N/A
  • Revenue This Year
  • SNDX N/A
  • FPF N/A
  • Revenue Next Year
  • SNDX N/A
  • FPF N/A
  • P/E Ratio
  • SNDX N/A
  • FPF N/A
  • Revenue Growth
  • SNDX N/A
  • FPF N/A
  • 52 Week Low
  • SNDX $12.06
  • FPF $13.91
  • 52 Week High
  • SNDX $25.34
  • FPF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 55.67
  • FPF 56.71
  • Support Level
  • SNDX $12.40
  • FPF $17.90
  • Resistance Level
  • SNDX $13.16
  • FPF $18.78
  • Average True Range (ATR)
  • SNDX 0.70
  • FPF 0.18
  • MACD
  • SNDX 0.24
  • FPF 0.08
  • Stochastic Oscillator
  • SNDX 90.73
  • FPF 72.84

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: